These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10326783)

  • 1. Depletion of brain norepinephrine: differential influence on anxiolyic treatment effects.
    Fontana DJ; McMiller LV; Commissaris RL
    Psychopharmacology (Berl); 1999 Apr; 143(2):197-208. PubMed ID: 10326783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic-like effects of alpha-2-adrenoceptor agonists on conflict behavior in the rat: pre- versus postsynaptic receptor mechanisms.
    Fontana DJ; Commissaris RL
    Pharmacol Biochem Behav; 1992 Nov; 43(3):697-704. PubMed ID: 1360159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conflict behavior in Maudsley reactive and nonreactive rats: effects of noradrenergic neuronal destruction.
    Verbanac JS; Altman HJ; Dhingra P; Harrington GM; Commissaris RL
    Pharmacol Biochem Behav; 1993 Jun; 45(2):429-38. PubMed ID: 8327548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple within-day conflict testing to define the time course of anxiolytic drug effects.
    Commissaris RL; Xie Z; Ninichuk PJ; Markovska VL
    Pharmacol Biochem Behav; 1996 Feb; 53(2):369-77. PubMed ID: 8808146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose subchronic imipramine treatment: effects on anxiety-like (conflict) behavior in rats.
    Commissaris RL; Hill TJ
    Anxiety; 1994-1995; 1(3):109-13. PubMed ID: 9160558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the acute effects of a tricyclic and a MAOI antidepressant on septal driving of hippocampal rhythmical slow activity.
    Zhu XO; McNaughton N
    Psychopharmacology (Berl); 1994 Mar; 114(2):337-44. PubMed ID: 7838927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.
    Griebel G; Curet O; Perrault G; Sanger DJ
    Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conflict behavior and the effects of 8-OHDPAT treatment in rats selectively bred for differential 5-HT(1A)-induced hypothermia.
    Commissaris RL; Ardayfio PA; McQueen DA; Gilchrist GA; Overstreet DH
    Pharmacol Biochem Behav; 2000 Sep; 67(1):199-205. PubMed ID: 11113501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant.
    Rossby SP; Nalepa I; Huang M; Perrin C; Burt AM; Schmidt DE; Gillespie DD; Sulser F
    Brain Res; 1995 Jul; 687(1-2):79-82. PubMed ID: 7583316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of DSP4 and desipramine in the sensorial and affective component of neuropathic pain in rats.
    Bravo L; Mico JA; Rey-Brea R; Camarena-Delgado C; Berrocoso E
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():57-67. PubMed ID: 27181607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of norepinephrine in forebrain and brainstem seizures: chemical lesioning of locus ceruleus with DSP4.
    Mishra PK; Burger RL; Bettendorf AF; Browning RA; Jobe PC
    Exp Neurol; 1994 Jan; 125(1):58-64. PubMed ID: 8307124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments.
    Balu DT; Hoshaw BA; Malberg JE; Rosenzweig-Lipson S; Schechter LE; Lucki I
    Brain Res; 2008 May; 1211():37-43. PubMed ID: 18433734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons.
    Hallman H; Jonsson G
    Eur J Pharmacol; 1984 Aug; 103(3-4):269-78. PubMed ID: 6237924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retarded acquisition of a temporal discrimination following destruction of noradrenergic neurones by systemic treatment with DSP4.
    Ho MY; Velazquez Martinez DN; Lopez Cabrera M; al-Zahrani SS; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1995 Apr; 118(3):332-7. PubMed ID: 7542393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of central noradrenergic neurons one year after the administration of the neurotoxin DSP4.
    Wolfman C; Abó V; Calvo D; Medina J; Dajas F; Silveira R
    Neurochem Int; 1994 Oct; 25(4):395-400. PubMed ID: 7820072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of destruction of noradrenergic neurones with DSP4 on performance on a free-operant timing schedule.
    Al-Zahrani SS; Al-Ruwaitea AS; Ho MY; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1998 Apr; 136(3):235-42. PubMed ID: 9566808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of beta-antagonists and anxiolytics on conflict behavior in the rat.
    Fontana DJ; McCloskey TC; Jolly SK; Commissaris RL
    Pharmacol Biochem Behav; 1989 Mar; 32(3):807-13. PubMed ID: 2568003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cocaine on conflict behavior in the rat.
    Fontana DJ; Commissaris RL
    Life Sci; 1989; 45(9):819-27. PubMed ID: 2770423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of central 5-hydroxytryptamine influence on the anticonflict activity of diazepam.
    Kilts CD; Commissaris RL; Cordon JJ; Rech RH
    Psychopharmacology (Berl); 1982; 78(2):156-64. PubMed ID: 6217479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic-like effects of the noncompetitive NMDA antagonist MK 801.
    Xie Z; Commissaris RL
    Pharmacol Biochem Behav; 1992 Oct; 43(2):471-7. PubMed ID: 1359577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.